Developing novel genome editing tools
In this Q&A, Dr Stephen Jones from Vilnius University Life Sciences Center discusses his work on the recent developments in genome editing tools at the university.
List view / Grid view
In this Q&A, Dr Stephen Jones from Vilnius University Life Sciences Center discusses his work on the recent developments in genome editing tools at the university.
Researchers at the University of Texas have redesigned a key component of a CRISPR-based gene-editing tool.
Inter-alpha inhibitor proteins (IAIP) demonstrated efficiency in reducing damage from an ischemic stroke, reveals pre-clinical study.
Using NMR spectroscopy, researchers have partially observed the structure of heat shock proteins that bind to proteins that cause Huntington's disease.
A new study has suggested that the enzyme GFPT2 could be a useful target for non-small cell lung cancer (NSCLC).
The Junior Editors of Drug Target Review, Victoria Rees and Hannah Balfour, discuss some of the most noteworthy news and announcements from this year.
A study has demonstrated that the LY6E protein inhibits SARS-CoV-2 infection in human cell cultures, so a drug mimicking it could be a therapy for COVID-19.
Drugs that were being developed to treat enterovirus have also been found to treat certain cancers in mice.
Scientists may have found a sensitive time period where autism related social deficits could be reversed in tuberous sclerosis...
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit computation within molecular systems...
7 March 2016 | By Victoria White
Scientists have provided a deeper insight into how BRCA1 functions in normal breast tissue and how its loss results in breast cancer...
9 December 2015 | By Victoria White
Researchers have identified the molecule, Tc24, that is expressed by Trypanosoma cruzi and may facilitate the parasite's evasion of the host's immune system...
3 December 2015 | By Victoria White
Preclinical testing demonstrated that the new antibodies work as a prophylaxis to provide short-term immunity and as a treatment to accelerate recovery...
24 August 2015 | By Victoria White
A research team led by The University of Texas Medical Branch have reported a new breakthrough in countering the deadly effects of radiation exposure...
9 June 2015 | By Victoria White
A new study has revealed that calcineurin inhibitor-based medications, such as Tacrolimus or cyclosporine, may also protect against Alzheimer’s disease...